down arrow

Brawn Biotech

  • Market Cap: Micro Cap
  • Industry: Trading
  • ISIN: INE899B01015
  • NSEID:
  • BSEID: 530207
INR
16.00
-0.7 (-4.19%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 1.05 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

16.0016.70

52 Week

15.4627.82
Valuation
Technical
Day's Volume

CASH

1.05 k (1,645.85%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.35%

Held by 0 DIIs

Promoter

53.64%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -24.15% and Operating profit at -210.40% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.27
2

Stock is technically in a Bearish range

3

Risky - Negative EBITDA

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Trading

stock-summary
Market cap

INR 5 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

22

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

-38.77%

stock-summary
Price to Book

1.18

Revenue and Profits (1 Year):
Net Sales:
4 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-22.14%
0%
-22.14%
1 Year
-11.85%
0%
-11.85%
2 Years
-2.91%
0%
-2.91%
3 Years
-14.67%
0%
-14.67%
4 Years
-29.98%
0%
-29.98%
5 Years
-18.16%
0%
-18.16%

Latest dividend: 1 per share ex-dividend date: Sep-12-2018

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-24.15%
EBIT Growth (5y)
-210.40%
EBIT to Interest (avg)
-1.27
Debt to EBITDA (avg)
0.23
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
3.06
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.35%
ROCE (avg)
-17.67%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
22
Price to Book Value
1.18
EV to EBIT
-2.76
EV to EBITDA
-2.96
EV to Capital Employed
1.20
EV to Sales
0.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-47.62%
ROE (Latest)
-38.77%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.35%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Brij Raj Gupta (16.67%)

Highest Public shareholder

Daksha Kotak (1.24%)

Individual Investors Holdings

33.2%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 16.36% vs -18.72% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -26.47% vs 35.85% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.84",
          "val2": "3.30",
          "chgp": "16.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.41",
          "val2": "-0.31",
          "chgp": "-32.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.43",
          "val2": "-0.34",
          "chgp": "-26.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-10.68%",
          "val2": "-9.39%",
          "chgp": "-1.29%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -27.91% vs -8.59% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -45.00% vs -172.73% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.36",
          "val2": "10.21",
          "chgp": "-27.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.82",
          "val2": "-0.55",
          "chgp": "-49.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.87",
          "val2": "-0.60",
          "chgp": "-45.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-11.14%",
          "val2": "-5.39%",
          "chgp": "-5.75%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -14.18% vs -25.34% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -7.44% vs -365.38% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.20",
          "val2": "13.05",
          "chgp": "-14.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.23",
          "val2": "-1.13",
          "chgp": "-8.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.30",
          "val2": "-1.21",
          "chgp": "-7.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-10.98%",
          "val2": "-8.66%",
          "chgp": "-2.32%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -25.82% vs 157.89% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -77.01% vs 46.95% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.49",
          "val2": "22.23",
          "chgp": "-25.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.53",
          "val2": "-0.30",
          "chgp": "-410.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.01",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.54",
          "val2": "-0.87",
          "chgp": "-77.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9.28%",
          "val2": "-1.35%",
          "chgp": "-7.93%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
3.84
3.30
16.36%
Operating Profit (PBDIT) excl Other Income
-0.41
-0.31
-32.26%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.43
-0.34
-26.47%
Operating Profit Margin (Excl OI)
-10.68%
-9.39%
-1.29%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 16.36% vs -18.72% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -26.47% vs 35.85% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
7.36
10.21
-27.91%
Operating Profit (PBDIT) excl Other Income
-0.82
-0.55
-49.09%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.87
-0.60
-45.00%
Operating Profit Margin (Excl OI)
-11.14%
-5.39%
-5.75%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -27.91% vs -8.59% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -45.00% vs -172.73% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
11.20
13.05
-14.18%
Operating Profit (PBDIT) excl Other Income
-1.23
-1.13
-8.85%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.30
-1.21
-7.44%
Operating Profit Margin (Excl OI)
-10.98%
-8.66%
-2.32%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -14.18% vs -25.34% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -7.44% vs -365.38% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
16.49
22.23
-25.82%
Operating Profit (PBDIT) excl Other Income
-1.53
-0.30
-410.00%
Interest
0.00
0.01
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.54
-0.87
-77.01%
Operating Profit Margin (Excl OI)
-9.28%
-1.35%
-7.93%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -25.82% vs 157.89% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -77.01% vs 46.95% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Brawn Biotech Ltd stock-summary
stock-summary
Brawn Biotech Ltd
Micro Cap
Trading
Brawn Biotech Ltd was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985. Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010. Brawn , with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt.
Company Coordinates stock-summary
Company Details
C-64 Lajpat Nagar-1 1st Floor , New Delhi New Delhi : 110024
stock-summary
Tel:
stock-summary
http://www.brawnbiotech.com
stock-summary
solution@brawnpharma.com
Registrar Details
RCMC Share Registry Pvt Ltd , B-106, Sector-2, Noida Noida Uttar Pradesh, Noida
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."